Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

57.1%

4 terminated/withdrawn out of 7 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results4 withdrawn

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 3

1(16.7%)

Phase 4

1(16.7%)

6Total

N/A(4)

Phase 3(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07169162Phase 4Withdrawn

ADZENYS XR-ODT™ in Children (4 to <6 Years) Diagnosed With Attention-deficit/Hyperactivity Disorder

Role: lead

NCT04572399Not ApplicableCompleted

UVA Light Device to Treat COVID-19

Role: collaborator

NCT05463679Phase 3Suspended

Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.

Role: lead

NCT02839447Withdrawn

A Clinical Evaluation of Semen Quality Using the MiOXSYS™ System 2.0

Role: lead

NCT05166915Not ApplicableWithdrawn

Respiratory COVID-19: A Randomized, Sham-Controlled Study

Role: lead

NCT04758260Not ApplicableWithdrawn

Influence of the Antioxidant Treatment in the Oxidant-reduction Potential in Seminal Plasma in Men Whose Partners Will Undergo Through an Egg Donation Cycle

Role: collaborator

NCT02786459Not ApplicableCompleted

Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study

Role: collaborator

All 7 trials loaded